Impact of serum amyloid A on cellular cholesterol efflux to serum intype 2 diabetes mellitus

Atherosclerosis

Volumn 231, Issue 2, 2013, Pages 405-410

  Tsun, J G S ^a   Shiu, S W M ^a   Wong, Y ^a   Yung, S ^a   Chan, T M ^a   Tan, K C B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

ATP binding cassette transporter G1; Cellular cholesterol efflux; High density lipoprotein; Reverse cholesterol transport; Scavenger receptor class B type I; Serum amyloid A

Indexed keywords

ABC TRANSPORTER G1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR BI; SERUM AMYLOID A; TRIACYLGLYCEROL;

ADULT; ANIMAL CELL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN TREATMENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ATP-BINDING CASSETTE TRANSPORTER G1; CELLULAR CHOLESTEROL EFFLUX; HIGH DENSITY LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; SCAVENGER RECEPTOR CLASS B TYPE I; SERUM AMYLOID A;

ADULT; AGED; ANIMALS; APOLIPOPROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CHO CELLS; CHOLESTEROL; CHOLESTEROL, HDL; CRICETINAE; CRICETULUS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; RATS; SCAVENGER RECEPTORS, CLASS B; SERUM AMYLOID A PROTEIN;

EID: 84888167079     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.10.008     Document Type: Article

References (31)

1. Eklund K.K., Niemi K., Kovanen P. Immune functions of serum amyloid a. Crit Rev Immunol 2012, 32:335-348.
2. Coetzee G.A., Strachan A.F., van der Westhuyzen D.R., Hoppe H.C., Jeenah M.S., de Beer F.C. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. JBiol Chem 1986, 261:9644-9651.
3. van der Westhuyzen D.R., de Beer F.C., Webb N.R. HDL cholesterol transport during inflammation. Curr Opin Lipidol 2007, 18:147-151.
4. Chait A., Han C.Y., Oram J.F., Heinecke J.W. Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?. JLipid Res 2005, 46:389-403.
5. Banka C.L., Yuan T., de Beer M.C., Kindy M., Curtiss L.K., de Beer F.C. Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux. JLipid Res 1995, 36:1058-1065.
6. Artl A., Marsche G., Lestavel S., Sattler W., Malle E. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 2000, 20:763-772.
7. Hayat S., Raynes J.G. Serum amyloid A has little effect on high density lipoprotein (HDL) binding to U937 monocytes but may influence HDL mediated cholesterol transfer. Biochem Soc Trans 1997, 25:348S.
8. Tam S.P., Flexman A., Hulme J., Kisilevsky R. Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1. JLipid Res 2002, 43:1410-1420.
9. Stonik J.A., Remaley A.T., Demosky S.J., Neufeld E.B., Bocharov A., Brewer H.B. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem Biophys Res Commun 2004, 321:936-941.
10. Annema W., Nijstad N., Tölle M., et al. Myeloperoxidase and serum amyloid A contribute to impaired invivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2. JLipid Res 2010, 51:743-754.
11. Pickup J., Crook M. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 1998, 41:1241-1248.
12. Zhou H., Tan K.C., Shiu S.W., Wong Y. Cellular cholesterol efflux to serum is impaired in diabetic nephropathy. Diabetes Metab Res Rev 2008, 24:617-623.
13. Bortnick A.E., Rothblat G.H., Stoudt G., et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. JBiol Chem 2000, 275:28634-28640.
14. Gelissen I.C., Harris M., Rye K.A., et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 2006, 26:534-540.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. JBiol Chem 1951, 193:265-275.
16. Cai L., de Beer M.C., de Beer F.C., van der Westhuyzen D.R. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. JBiol Chem 2005, 280:2954-2961.
17. Jessup W., Gelissen I.C., Gaus K., Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 2006, 17:247-257.
18. Rosenson R.S., Brewer H.B., Davidson W.S., et al. Cholesterol efflux and atheroprotection advancing the concept of reverse cholesterol transport. Circulation 2012, 125:1905-1919.
19. Khera A.V., Cuchel M., de la Llera-Moya M., et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. NEngl J Med 2011, 364:127-135.
20. Pajunen P., Syvänne M., Castro G., Nieminen M.S., Taskinen M.R. Cholesterol efflux capacity invitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes. Scand Cardiovasc J 2001, 35:96-100.
21. Syvänne M., Castro G., Dengremont C., et al. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary arterydisease and non-insulin-dependent diabetes: importance of LpA-I: A-II particles and phospholipid transfer protein. Atherosclerosis 1996, 127(2):245-253.
22. Holzer M., Birner-Gruenberger R., Stojakovic T., et al. Uremia alters HDL composition and function. JAm Soc Nephrol 2011, 22:1631-1641.
23. Dalla Vestra M., Mussap M., Gallina P., et al. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. JAm Soc Nephrol 2005, 16:S78-S82.
24. Johnson B.D., Kip K.E., Marroquin O.C., et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women. Circulation 2004, 109:726-732.
25. Kosuge M., Ebina T., Ishikawa T., et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J 2007, 71:186-190.
26. King V.L., Thompson J., Tannock L.R. Serum amyloid A in atherosclerosis. Curr Opin Lipidol 2011, 22:302-307.
27. Marhaug G., Sletten K., Husby G. Characterization of amyloid related protein SAA complexed with serum lipoproteins (apoSAA). Clin Exp Immunol 1982, 50:382-389.
28. Marsche G., Frank S., Raynes J.G., Kozarsky K.F., Sattler W., Malle E. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. Biochem J 2007, 402:117-124.
29. Thuahnai S.T., Lund-Katz S., Dhanasekaran P., et al. Scavenger receptor class B type I-mediated cholesteryl ester-selective uptake and efflux of unesterified cholesterol. Influence of high density lipoprotein size and structure. JBiol Chem 2004, 279:12448-12455.
30. Khovidhunkit W., Shigenaga J.K., Moser A.H., Feingold K.R., Grunfeld C. Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. JLipid Res 2001, 42:967-975.
31. de Beer M.C., Ji A., Jahangiri A., et al. ATP binding cassette G1-dependent cholesterol efflux during inflammation. JLipid Res 2011, 52:345-353.